Theravance Biopharma Inc (TBPH) Insider Trading
- $29,986,863,717,436.00
- $8,588,174.31
- Nov. 11, 2024
- Richard A Graham
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Oct. 7, 2015 | Major Shareholder | 44,574 | $607,544.00 | Buy | $27,080,666,256.00 | |
| Aug. 18, 2015 | VP | 9,000 | $12.90 | Buy | $116,100.00 | |
| Aug. 18, 2015 | Director | 10,000 | $12.92 | Buy | $129,200.00 | |
| Aug. 17, 2015 | CFO | 10,000 | $12.18 | Buy | $121,800.00 | |
| Aug. 17, 2015 | CEO | 80,000 | $11.86 | Buy | $948,800.00 |
Insiders are both buying and selling Theravance Biopharma Inc stock.
The insider traders at Theravance Biopharma Inc are: Richard A Graham, Rhonda Farnum, Bradford J Shafer, Brett K Haumann, Philip D Worboys, Rick E Winningham, Renee D Gala, Burton G Malkiel, Plc Glaxosmithkline, Donal O'connor, Sharathchandra S Hegde, Frank Pasqualone, Vijay Sabesan, Henrietta Fore, Junning Lee, and Eli Samaha
The most active insider trader at Theravance Biopharma Inc is Richard A Graham with 14 trades.
Bradford J Shafer has sold the most Theravance Biopharma Inc stock with a total value of $3,650,154.40.
Plc Glaxosmithkline has bought the most Theravance Biopharma Inc stock with a total value of $59,946,627,506,256.00.
The most recent insider trade for Theravance Biopharma Inc was on Nov. 11, 2024.
The single biggest insider buy for Theravance Biopharma Inc was from Plc Glaxosmithkline with a total value of $29,959,773,420,000.00 on March 14, 2016.
The single biggest insider sell for Theravance Biopharma Inc was from Bradford J Shafer with a total value of $1,348,890.12 on Aug. 22, 2016.